Divi's Laboratories Ltd. (DIVISLAB)
BSE
Closed
Aug 26, 2026
Day's Range
8,703.8552 wk Range
5,637.50Overview - DIVISLAB - Divi's Laboratories Ltd.
Key Statistics
Valuation
Enterprise Value
2.27T
P/E (Trailing)
‪92.94‬
P/E (Forward)
‪59.90‬
PEG Ratio
‪3.37‬
Price / Sales (TTM)
‪21.28‬
Price / Book
‪14.26‬
EV / EBITDA
‪57.29‬
Profitability
Gross Margin
‪60.47%‬
Profit Margin
‪26.04%‬
Operating Margin
‪36.65%‬
Return on Assets
‪12.81%‬
Return on Equity
‪15.32%‬
Ownership
Shares Outstanding
265.46M
Float
117.26M
Held by Insiders
‪51.99%‬
Held by Institutions
‪30.29%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪7,480.39‬
200-Day Avg
‪6,644.46‬
Dividends
Payout Ratio
‪31.01%‬
Frequency
Annual
Analyst Consensus
29 analysts
Market Cap - DIVISLAB - Divi's Laboratories Ltd.
Peers - DIVISLAB - Divi's Laboratories Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- DIVISLABBSEDivi's Laboratories Ltd.2.25TMarket Cap+27.45%52-week change87.72P/E (Trailing)‪26.04%‬Profit Margin
- CIPLABSECipla Ltd.1.14TMarket Cap-11.64%52-week change25.39P/E (Trailing)‪16.25%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.00TMarket Cap+54.36%52-week change89.19P/E (Trailing)‪15.04%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.994.50BMarket Cap-6.92%52-week change17.61P/E (Trailing)‪16.36%‬Profit Margin
- LUPINBSELupin Ltd.993.90BMarket Cap+12.76%52-week change23.24P/E (Trailing)‪17.47%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.977.56BMarket Cap-2.49%52-week change48.14P/E (Trailing)‪13.85%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.932.58BMarket Cap+36.57%52-week change27.31P/E (Trailing)‪10.52%‬Profit Margin
Profile Summary - DIVISLAB - Divi's Laboratories Ltd.
About
Divi's Laboratories Ltd. is a pharmaceutical company based in India, known for its significant role in the global pharmaceuticals industry as a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1990, the company focuses on the development and production of generic and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
